Last reviewed · How we verify
NCT04457440
Cognitive Behavioral Sleep Intervention for Prevention of Type 2 Diabetes
NA trial testing Intensive Lifestyle Intervention in PreDiabetes in 36 participants. Suspended.
30 December 2021
Quick facts
| Lead sponsor | The University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Suspended |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 1 July 2020 |
| Primary completion | 30 December 2021 |
| Estimated completion | 30 December 2021 |
| Sites | 2 locations across Hong Kong |
Drugs / interventions tested
- Intensive Lifestyle Intervention
- Intensive Lifestyle Intervention enhanced with Cognitive Behavioral Sleep Intervention
Conditions studied
- PreDiabetes — all drugs for PreDiabetes →
- Insomnia — all drugs for Insomnia →
- Sleep Deprivation — all drugs for Sleep Deprivation →
Sponsor
The University of Hong Kong
Who can join
Adults 18 to 65, any sex, with PreDiabetes or Insomnia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The proposed study aims to evaluate if improving sleep could enhance the intensive lifestyle intervention for improving weight loss and glycemic control in prediabetic individuals who have insomnia with short sleep duration. A cognitive behavioral intervention for insomnia with adjustments aimed at increasing sleep duration (CBT-Sleep) will be used for this study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04457440
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intensive Lifestyle Intervention
Trials testing the same drug.
- NCT06921304 — BASE-DIET: a Study on Nutritional Intervention in Patients With Graves' Disease · NA · active not recruiting
- NCT05523375 — Promoting Successful Weight Loss in Primary Care in Louisiana Using Information Technology · NA · active not recruiting
- NCT04116905 — Intensive Lifestyle Intervention for Remission of Metabolic Syndrome · NA · completed
- NCT02615353 — Preventing Diabetes in Latino Youth · NA · completed
- NCT02409238 — Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study · Phase 4 · terminated
Other recruiting trials for PreDiabetes
Currently open trials in the same condition.
- NCT06897982 — Feasibility of a Nutrition Intervention for Patients With Prediabetes at a Federally Qualified Health Center · NA · recruiting
- NCT06967558 — The Role of Islet GLP-1 in the Pathogenesis of Prediabetes · Phase 2 · recruiting
- NCT06482944 — Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes · NA · recruiting
- NCT06989164 — Post Prandial Individual Responses to Different Foods · NA · recruiting
- NCT07254572 — Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes · Phase 4 · recruiting
Other The University of Hong Kong trials
Trials by the same sponsor.
- NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
- NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
- NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
- NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
- NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04457440 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
- Last refreshed: 25 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04457440.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing